Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial.

about

Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial.

Item

http://www.wikidata.org/entity/Q53819014

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@en

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@nl

type

Item

label

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@en

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@nl

prefLabel

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@en

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@nl

P1476

Heat shock protein peptide com ...... : a phase I, single-arm trial.

@en

P2093

Jian Xie

http://www.w3.org/2001/XMLSchema#string

Nan Ji

http://www.w3.org/2001/XMLSchema#string

Shuyu Hao

http://www.w3.org/2001/XMLSchema#string

Yang Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

Yunpeng Liu

http://www.w3.org/2001/XMLSchema#string

Zhixian Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy advances for glioblastoma

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.

Immunosuppressive mechanisms in glioblastoma.

Isocitrate dehydrogenase mutations in gliomas

IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry.

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

P31

scholarly article

P356

10.1172/JCI.INSIGHT.99145

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29769450

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

6012501

http://www.w3.org/2001/XMLSchema#string